世界中医药
文章摘要
引用本文:张玲.丹红注射液治疗肝硬化42例疗效观察[J].世界中医药,2011,6(1):.  
丹红注射液治疗肝硬化42例疗效观察
Research on Effects of Danhong Injection on 42 patients with Liver Cirrhosis
投稿时间:2010-10-12  
DOI:
中文关键词:  肝硬化/中医药疗法  丹红注射液
English Keywords:Liver cirrhosis /Chinese Medical therapy  Danhong Injection
基金项目:
作者单位
张玲 连云港市中医院消化科江苏省连云港市新浦区朝阳中路160号222000 
摘要点击次数: 1127
全文下载次数: 1188
中文摘要:
      目的:观察丹红注射液治疗肝硬化的临床疗效。方法:选择肝功能异常以及血清肝纤维化指标异常的肝硬化患者82例,随机分为治疗组(42例)和对照组(40例)。治疗组在常规护肝治疗基础上,静脉点滴丹红注射液(丹参、红花),对照组给予常规的护肝治疗,疗程均为30天。观察治疗后2组肝功能及肝纤维化指标(HA、LN、IV-C、PC-III)变化。结果:肝功能(TBil、ALT等)2组疗效无显著性差异,但血清肝纤维化指标2组有显著性差异(P<005或P<001)。结论:丹红注射液能有效地改善肝病患者微循环,降低肝脏纤维化,对肝硬化的治疗具有良好的前景。
English Summary:
      To investigate effects of Danhong Injection on liver cirrhosis.Methods:Eighty-two patients with liver cirrhosis were randomized to two groups, i.e. control group (n=42) and treatment group (n=40). Danhong Injection was given to treatment group, as an add-on treatment to routine treatment, over a period of 30 days. At end of the treatment period, liver function and cirrhosis parameters(HA、LN、IV-C、PC-III) were observed. Results:Significant differences were measured between two group with plasma cirrhosis parameters (P<0.05 or P<0.01), but not with liver function parameters (TBil, ALT etc.). Conclusion: Danhong Injection can improve microcirculation of the patients with liver illness, decrease liver cirrhosis, thus present promising prospects.
查看全文  查看/发表评论  下载PDF阅读器